Comment Deadline: FDA Opioid Policy Steering Committee – Prescribing Intervention—Exploring a Strategy for Implementation

The Food and Drug Administration (FDA) is seeking public comments for its public hearing entitled, “Opioid Policy Steering Committee: Prescribing Intervention—Exploring a Strategy for Implementation.” The purpose of the public hearing is to receive stakeholder input on how FDA might, under its Risk Evaluation and Mitigation Strategy (REMS) authority, improve the safe use of opioid analgesics by curbing overprescribing to decrease the occurrence of new addictions and limit misuse and abuse of opioid analgesics.

Members of the public may submit comments via or by mail. More information is available via the Federal Register notice.

Event Date
Friday, March 16, 2018 - 5:00pm